Avalanche Biotechnologies, Inc. 4
4 · Avalanche Biotechnologies, Inc. · Filed Dec 11, 2015
Insider Transaction Report
Form 4
Cleveland Paul B
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2015-12-09+910,000→ 910,000 totalExercise: $9.04Exp: 2025-12-09→ Common Stock (910,000 underlying)
Footnotes (1)
- [F1]Twenty-Five Percent (25%) of the total shares subject to the option vest and become exercisable on the first anniversary of December 9, 2015 (the "Vesting Commencement Date") and 1/48 of the total shares subject to the option shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on the applicable vesting dates, so that all of the shares subject to the option are vested and exercisable on the fourth anniversary of the Vesting Commencement Date.